Delivery Order SPE2DB22D3016-SPE2DB25FBDP2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,014.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single shipment of this anticonvulsant and mood-stabilizing medication,...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.84 to AmerisourceBergen Drug Corp for 100 sprinkle capsules of Depakote DR 125 mg, an anticonvulsant and mood-stabilizing medication commonly used in military and veteran healthcare systems. This non-set-aside contract reflects a firm fixed price arrangement with a place of performance in Conshohocken, Pennsylvania, and was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, with a ceiling value of $1,824.98 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depakote DR 125 mg sprinkle capsules. The Delivery Order, valued at $1,350.72, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
- This delivery order, awarded August 5, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, procures 100 sprinkle capsules of Depakote DR 125 mg at a ceiling value of $2,156.71. The order is for firm fixed price delivery to the vendor's headquarters location in Conshohocken, Pennsylvania, with completion scheduled for August 6, 2025. This award was competitively awarded with no set-aside designation and represents a child contract action under AmerisourceBergen's larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Depakote DR 125 mg sprinkle capsules, with a potential value of $1,681.50 and a period of performance through January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceuticals and medical supplies to support military treatment programs and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,548,337 units of the medication Depakote DR 125 mg sprinkle capsules, with an ultimate completion date of June 16, 2025 and a ceiling value of $2,055.23. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,670,837 units of Depakote DR 125 mg sprinkle capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,428.18 and a completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDP2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen holds significant federal contracting capability and regularly fulfills competitively awarded orders across multiple therapeutic domains, including neurological treatments such as Depakote, which is commonly used for seizure management and mood stabilization in military and veteran healthcare systems. The company supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through this flexible contract framework, demonstrating its critical role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/30/25 |